These posters, oral presentations, and/or abstracts are provided for medical and scientific purposes only, they may include investigational use or agents that are not approved by health authorities. The information presented is not meant to convey conclusions of safety or effectiveness prior to any regulatory approval from a health authority.
Sanofi does not recommend the use of any products in a manner inconsistent with that described in the full prescribing information. Please refer to the prescribing information in your country of practice for any medicinal products mentioned.
Availability of posters and/or abstracts on this site will conform with conference embargo policies. By selecting “Accept”, you are certifying that you are a Healthcare Professional.
ISPOR EU 2026 | Nov 8, 2026 - Nov 11, 2026
Multiple sclerosis (MS) is an autoimmune disorder that causes neuroinflammation in the brain and spinal cord. The resulting lesions can either shrink or remain "chronically active" over the course of years, leading to accelerated loss of brain volume. This leads to unpredictable symptoms, such as vision problems, challenges with cognition, and difficulty with physical activity.
